Mucormycosis: Four case reports

Tunisie Medicale

Volumn 86, Issue 2, 2008, Pages 165-168

  Ammari, Lamia ^a   Kilani, Badreddine ^a   Tiouiri, Hanène ^a   Kanoun, Fakher ^a   Goubontini, Ahmed ^a   Mnif, Emna ^a   Zouiten, Fayçal ^a   Chaker, Emna ^a   Chaabane, Taoufik Ben ^a  

^a LA RABTA HOSPITAL   (Tunisia)

Author keywords

Diabetes mellitus; Mucormycosis; Rhizopus; Therapy

Indexed keywords

AMPHOTERICIN B; CEFAZOLIN; CEFOTAXIME; GENTAMICIN; METRONIDAZOLE; ANTIFUNGAL AGENT;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEBRIDEMENT; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; FEMALE; HUMAN; MALE; MUCORMYCOSIS; OUTCOME ASSESSMENT; PROGNOSIS; RADIODIAGNOSIS; MIDDLE AGED; RETROSPECTIVE STUDY;

ADULT; AGED; AMPHOTERICIN B; ANTIFUNGAL AGENTS; DEBRIDEMENT; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCORMYCOSIS; RETROSPECTIVE STUDIES;

EID: 44449086350     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Berrylin J, Ferguson Md. Mucormycosis of the nose and paranasal sinuses. Otolaryngologic clinics of North America 2000; 33: 349-365
2. Alan Ms. Mucormycosis. Clin.Infect.Diseases 1992; 14(suppl):126-129
3. Prabhu Rm, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin.Microbiol.Infect. 2004; 10(suppl): 31-47. (Pubitemid 38379950)
4. Livio P, Paolo R, Anna T, et al. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. Br.J.of Haematology 1997; 99: 331-336 (Pubitemid 27497563)
5. Nollaig A, Parferey Mb. Improved and prognosis of mucormycosis (Aclinicopathologic study of 33 cases). Medecine 1986; 65: 113-123 (Pubitemid 16099671)
6. Warwar Re, Bullock Jd. Rhino-orbital-cerebral mucormycosis: a review. Orbit 1998; 17: 237-245
7. Gayet Delacroix M, Dupas B, Legent F, Beauvillain C. Sinusites fongiques et granulomatoses. Imagerie maxillo-faciale. 4ème ed. Flammarion et Cie, 1997.
8. Dannaoui E, Meletiadis J, Mouton Jw, Meis Jm, Verweij PE. In vitro susceptibilities of zygomycetes to conventionnal and new antifungals. J. Antimicrobial Chemotherapy 2003; 51: 45-52.
9. Greenberg Rn, Scott Lj, Vaughn Hh, Ribes Ja. Zygomycosis (mucormycosis): emerging clinical importance and new treatments. Current Opinion in Infect.Dis 2004; 17: 517-525
10. Kok J, Gilroy N, Halliday C, et al. Early use of posaconazole in the successful treatment of rhino-orbital mucormycosis caused by Rhizopus oryzae. Journal of Infection 2007; 55: 33-36. (Pubitemid 47244921)